Please wait...

International Awareness day of Chronic Immunological and Neurological diseases – 12 May 2020


International Awareness Day for Chronic Immunological and Neurological Diseases

The International Awareness Day for Chronic Immunological and Neurological Diseases (CIND) is observed on May 12 every year since 1992. Myalgic Encephalomyelitis (ME)/ Chronic Fatigue Syndrome (CFS), Fibromyalgia (FM), Multiple Chemical Sensitivities (MCS) and Gulf War Syndrome (GWS) are collectively known as Chronic Immunological and Neurological Diseases (CIND).

The day is designated to spread awareness among people about CIND and help the world to understand the seriousness of these diseases and conditions. It also aims to assist and educate patients, patient support groups and organizations, healthcare professionals about CIND.

May 12 was chosen as it coincided with the birth date of Florence Nightingale, the English army nurse who inspired the founding of the International Red Cross. Nightingale was believed to have suffered from ME/CFS like illness.

These illnesses, characterized by cognitive problems, chronic muscle and joint pain, extremely poor stamina, and numerous other symptoms, afflict people around the world in alarming numbers.

Myalgic Encephalomyelitis (ME)/ Chronic Fatigue Syndrome (CFS) is a severe chronic illness in which symptoms are increased by physical exertion. Patients with CFS suffer from unexplained recurrent physical and mental fatigue, muscle and joint pain, sleep problems with neurological and cognitive manifestations. For making a diagnosis, symptoms must last for at least six months in adults and three months in children.

Fibromyalgia (FM) is a syndrome of widespread pain, aching and stiffness of muscles, often accompanied by fatigue, sleep disturbances and multiple tender points. Detail information about fibromyalgia can be seen at

Multiple Chemical Sensitivity (MCS) is also known as environmental sensitivities (ES) or intolerance. It is an acquired environment linked condition and is sometimes associated with myalgic encephalomyelitis/ chronic fatigue syndrome and fibromyalgia. The symptoms are reproducible with (repeated chemical) exposure and include headaches, problems with balance and coordination, nervousness, irritability and depressed mood, burning and irritated eyes, stuffy or runny nose, cough, fast or irregular heartbeat, nausea, diarrhoea or constipation, frequent or urgent urination, achy muscles and joints, and rashes.

Management of CIND

Awareness about the disease is important for patients as they learn to manage their illness by using various approaches. Medical treatment and patient’s self-care with healthy lifestyle behaviour can help to cope better with CNID. It includes:

  • Regular exercise plan
  • Proper rest and relaxation
  • Proper sleep
  • Good dietary habits
  • Avoidance of specific known environmental aggravators

Cognitive behaviour therapy and pharmacological treatment may be used with the consultation of physician for the management of symptoms causing major impairment.


  • PUBLISHED DATE : Jun 07, 2018
  • CREATED / VALIDATED BY : Dr. Aruna Rastogi
  • LAST UPDATED BY : Jun 07, 2018

For more information on each illness, please see the following pages

Other illnesses that fall under the CIND umbrella include:

  • Addison’s
  • Alzheimer’s
  • Autism
  • Celiac
  • Chronic Myofascial Pain
  • Crohn’s
  • Epilepsy
  • Irritable Bowel Disease (IBD)
  • Lou Gehrig’s (ALS)
  • Lupus
  • Lyme Disease
  • Mold/Biotoxin Illness
  • Multiple Sclerosis (MS)
  • Orthostatic Intolerance (OI)
  • Parkinson’s
  • Postural Orthostatic Tachycardia Syndrome(POTS)
  • Reflex Sympathetic Dystrophy Syndrome (RSD)
  • Ulcerative Colitis



The Optima Psychiatric Hospital, a healing centre, situated in the Bloemfontein suburb, Hospitaalpark, accommodating 76 patients and is operated by a company consisting of nine partners, all Psychiatrists.

Contact Details

17 Addison St, Bloemfontein, 9301
Phone: 051 502 1800
© 2022 M-Care Optima - Website design & development by Digital Platforms